Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.48 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.48 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.48 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32684489 | 1.00 | KMT2A (0.56) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL6139167 | 1.00 | KMT2A (0.56) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL9716546 | 1.00 | KMT2A (0.56) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL3638907 | 0.98 | CYP3A4 (0.56) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL4079668 | 0.94 | CYP3A4 (0.57) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL688275 | 0.92 | CYP3A4 (0.58) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL809344 | 0.92 | CYP3A4 (0.58) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL689630 | 0.92 | CYP3A4 (0.58) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL16974800 | 0.92 | POLM (0.54) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL16974801 | 0.92 | POLM (0.54) | KMT2AMEN1ALDH1A1MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-5242805-A | Useful in directingcells producing enzymes that hydrolyze the glycoside | MOLECULAR PROBES, INC. (US) | 1993-09-07 | — | — | US | disclosed |
| WO-1993004074-A1 | LONG WAVELENGTH LIPOPHILIC FLUOROGENIC GLYCOSIDASE SUBSTRATES | MOLECULAR PROBES, INC. (US) | 1993-03-04 | — | — | WO | disclosed |
| US-4611016-A | ORGANIC POLYMERIC MATERIALS | CIBA-GEIGY CORP. (US) | 1986-09-09 | — | — | US | disclosed |
| US-4325863-A | POLYMERS | SANDOZ LTD. (CH) | 1982-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | KMT2A 3395/4885MEN1 4840/4885ALDH1A1 697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.